Home » Topics » Regulatory » Patents

Patents
RSS

COX-2 inhibitors claimed by AHP for arthritis, cancer and AD

April 20, 1998

Novel cell adhesion inhibitors discovered at Biogen

April 20, 1998

Synthetic dolastatin derivatives as antitumor agents

April 20, 1998

New endothelin antagonists from Bristol-Myers Squibb

April 20, 1998

ICAgen and Lilly disclose potassium channel inhibitors

April 17, 1998

Agents for urinary incontinence and IBS in development at Pharmacia & Upjohn

April 17, 1998

Selective beta3-adrenoceptor agonists from Merck & Co. for obesity, diabetes

April 17, 1998

Novel dopaminergic compounds in the pipeline at ADIR

April 17, 1998

ViroPharma's new antiinfluenza agents

April 17, 1998

Selective MMP-13 inhibitors in the pipeline at Monsanto

April 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...